Helmholtz Association promotes HZB cooperation with Slovenia on perovskite silicon tandem solar cells
Marko Jošt was a PhD student in the HySPRINT-Lab in Steve Albrecht's group. Now he will continue his research on tandem solar cells at the university of Lubljana. © M. Setzpfandt/ HZB
A HZB team has successfully raised funds from the “Helmholtz European Partnering Program” of the Helmholtz Association to expand cooperation with partners of the University of Ljubljana, Slovenia. The topics of the cooperation are tandem solar cells made of perovskite and silicon and, in particular, their precise characterisation.
Currently, most solar modules consist of silicon, a semiconductor that mainly uses the red parts of the solar spectrum to generate electricity. The combination of silicon with perovskite semiconductors therefore promises great opportunities for even higher efficiencies. Semiconductor materials from this material class convert the energy-rich, blue parts of the spectrum into electricity.
Now the HZB physicist Prof. Dr. Steve Albrecht has raised funds from the Helmholtz Association to investigate such tandem solar cells with partners from the University of Ljubljana, Slovenia. The TAPAS project is funded by the Helmholtz European Partnering programme for the next three years with 250,000 euros per year each. Following an evaluation, the funding period can be extended by two years. The Helmholtz European Partnering programme was set up to strengthen the European research area, in particular cooperation with countries in Southern, Central and Eastern Europe.
The name TAPAS stands for "Tandem Perovskite and Silicon solar cells - Advanced opto-electrical characterization, modeling and stability". Together with opto-electrical modelling, highly efficient and stable next-generation tandem solar cells are to be developed for the energy system of the future.
The Working Group for Photovoltaics and Optoelectronics at the University of Ljubljana (LPVO, headed by Prof. Dr Marko Topič) and the Helmholtz-Zentrum Berlin have established a very successful cooperation in recent years, which will be further strengthened by this funding. The aim of the cooperation is to analyse the processes that affect the stability of the modules in the field.
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.